Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits.
Anusha McNamaraMilly ZhaoShin-Yu LeePublished in: Journal of the American College of Clinical Pharmacy : JACCP (2021)
These results provide a start to establish criteria for which patients should be seen by a clinical pharmacist in person vs over the phone.